Skip to main content

Advertisement

Log in

Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The objective was to determine if the plasma concentrations of salbutamol, obtained during inhalation treatment of infantile acute asthma, are influenced by age range and by the aerosol system used.

Method

A randomized clinical trial was conducted in 46 children (1–5 years of age) with a diagnosis of acute asthma crisis, established in an emergency room pediatric service. Twenty-five children received salbutamol using a pressurized metered-dose inhaler with spacer (50 µg/kg), and 21 children received salbutamol by nebulization (150 µg/kg),three times during a 1-h period. At the end of the treatment, one blood sample was drawn and the plasma was stored for later determination of salbutamol concentration (liquid chromatography). Salbutamol plasma concentrations were compared in two age groups (≤2 years and >2 years of age). The type of device used (pressurized metered-dose inhaler or nebulizer) and the need of hospitalization were also tested. The Mann-Whitney U test was used with the level of significance set at 5% (P < 0.05).

Results

No differences were detected regarding either the aerosol delivery system used or the need for hospitalization in relation to the plasma concentrations of salbutamol. However, higher plasma levels were found in patients >2 years vs patients ≤2 years [median (IQR): 9.40 (6.32–18.22) vs. 4.65 (2.77–10.10) ng/mL], demonstrating a significance difference (P = 0.05).

Conclusion

Salbutamol plasma concentrations were influenced by age group of the patients submitted to inhalation therapy, even with doses adjusted for body weight. After correcting for the differences in the biovailabilities of the delivery systems, the concentrations were independent of the aerosol delivery device used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rubilar L, Rodriguez-Castro JA, Girardi G (2000) Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatric Pulmonol 29:264–269

    Article  CAS  Google Scholar 

  2. Benedito-Fernández J et al (2004) Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department. Pediatric Emerg Care 20:656–659

    Article  Google Scholar 

  3. Amirav I, Newhouse MT (1997) Metered-dose inhaler accessory devices in acute asthma. Arch Pediatr Adolesc Med 151:876–882

    CAS  PubMed  Google Scholar 

  4. Amantéa SL et al (2002) Controvérsias no manejo farmacológico da asma aguda infantil. J Pediatr (Rio J) 78(Supl.2):S151–S160

    Google Scholar 

  5. Lipworth BJ, Clark DJ (1997) Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax 52:1036–1039

    Article  CAS  PubMed  Google Scholar 

  6. Closa RM, Ceballos JM, Gomez-Papí A et al (1998) Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatric Pulmonol 26:344–348

    Article  CAS  Google Scholar 

  7. Isler FA, Newth CJL (1995) Management of acute asthma in children. Baillieres Clin Paediatr 3:341–378

    Google Scholar 

  8. Reinhardt D et al (1984) Age-dependency of alpha and beta-adrenoceptors on thrombocytes and lymphocytes of asthmatic and nonasthmatic children. Eur J Pediatr 142:111–116

    Article  CAS  PubMed  Google Scholar 

  9. Browne GJ et al (1997) Randomized trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 49:301–305

    Article  Google Scholar 

  10. Global Initiative for Asthma (GINA) (2009) Pocket guide for asthma management and prevention in children 5 years and younger. http://www.ginasthma.org

  11. Rotta ET, Amantéa SL, Froehlich PE, Becker A (2007) Determining salbutamol plasma concentrations after nebulization in pediatric emergency department. J Ped (RioJ) 83(5):481–484

    Google Scholar 

  12. Hutchings MJ, Paull JD, Morgan DJ (1983) Determination of salbutamol in plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 277:423–426

    Article  CAS  PubMed  Google Scholar 

  13. Penna AC et al (1993) Systemic absorption of salbutamol following nebulizer delivery in acute asthma. Acta Paediatr 82:963–966

    Article  CAS  PubMed  Google Scholar 

  14. Schuh S, Reider MJ, Canny G et al (1990) Nebulized albuterol in acute childhood asthma: comparison of two doses. Pediatrics 86:509–513

    CAS  PubMed  Google Scholar 

  15. Kerem E et al (1993) Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. Pediatr Pharmacol Ther 123:313–317

    CAS  Google Scholar 

  16. Cates CJ et al (2006) Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000052.pub2

  17. Deerojanawong J et al (2005) Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs jet nebulizer in young with children wheezing. Pediatr Pulmonol 39:466–472

    Article  CAS  PubMed  Google Scholar 

  18. Schuh S et al (1999) Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr 135:22–27

    Article  CAS  PubMed  Google Scholar 

  19. Ploin D et al (2000) High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: a double-blind, randomized equivalence trial. Pediatrics 106:311–331

    CAS  PubMed  Google Scholar 

  20. Delgado A et al (2003) Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatric Adolesc Med 157:76–80

    Google Scholar 

  21. Bonnelykke K, Jespersen JJ, Bisgaard H (2007) Age dependent systemic esposure to inhaled salbutamol. Br J Clin Pharmacol 64:241–244

    Google Scholar 

  22. Lipworth B (1996) Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 42:697–705

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work is connected with the Post-Graduation Program in Health Sciences, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA), RS, Brazil. The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sérgio L. Amantéa.

Additional information

Specific contribution of each author: Eloni Rotta participated in the collection and analysis of the data and wrote the initial manuscript; Sérgio L. Amantéa conceptualized and planned the study, participated in the analysis of the data and edited the final draft of the article; Adriana Becker participated in the collection, analysis and writing of the paper at the end of the study; Pedro E. Froehlich participated in the planning, validation of the analytical process, and writing of paper at the end of the study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotta, E.T., Amantéa, S.L., Froehlich, P.E. et al. Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?. Eur J Clin Pharmacol 66, 605–610 (2010). https://doi.org/10.1007/s00228-010-0787-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0787-4

Keywords

Navigation